Gene · 10846
Papers1,053
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,053
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characterization of normal and physiologically suppressed human parathyroid glands at single-cell resolution. | J Endocr Soc | 2026 | 42761548 | PubTator, text mining | PubMed |
| Adaptations to breath-hold diving: from traditional divers to elite athletes. | Diving Hyperb Med | 2026 | 42743578 | PubTator, text mining | PubMed |
| Paraneoplastic neurological syndromes: an update on incidence, antibody discovery, and testing. | Curr Opin Oncol | 2026 | 42710022 | PubTator, text mining | PubMed |
| Developing a Phosphodiesterase 10A Inhibitor as a Novel Therapeutic Agent for Triple-Negative Breast Cancer. | Cells | 2026 | 42587783 | PubTator, text mining | PubMed |
| PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL'36) in Patients Experiencing Acute Schizophrenia. | CNS Drugs | 2026 | 42533223 | PubTator, text mining | PubMed |
| Identification of PDE10A binding ligands as potential therapeutics for the Parkinson's disease through a computational approach. | Sci Rep | 2026 | 42426040 | PubTator, text mining | PubMed |
| Smooth Muscle Cell-Specific Expression of Cyclic Nucleotide Phosphodiesterase 10a Promotes the Development of Medial Artery Calcification. | J Am Soc Nephrol | 2026 | 42308131 | PubTator, text mining | PubMed |
| No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of View. | Neurol Int | 2026 | 41893061 | PubTator, text mining | PubMed |
| Association of maternal smoking during pregnancy with youth depression and subsequent adult chronic diseases in offspring. | Transl Psychiatry | 2026 | 41888109 | PubTator, text mining | PubMed |
| CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development. | PeerJ | 2026 | 41868793 | PubTator, text mining | PubMed |
| Mechanism of action and clinical application of autophagy in multiple sclerosis (Review). | Int J Mol Med | 2026 | 41860040 | PubTator, text mining | PubMed |
| Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. | Medicine (Baltimore) | 2026 | 41790675 | PubTator, text mining | PubMed |
| Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential. | Bone Rep | 2026 | 41732176 | PubTator, text mining | PubMed |
| Single-cell analysis reveals the cellular and transcriptional heterogeneity of the normal pediatric thyroid. | Front Endocrinol (Lausanne) | 2026 | 41727685 | PubTator, text mining | PubMed |
| Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia. | J Clin Psychopharmacol | 2026 | 41724750 | PubTator, text mining | PubMed |
| Developments and challenges in hit progression within fragment-based drug discovery. | Nat Commun | 2026 | 41620434 | PubTator, text mining | PubMed |
| Female sex is a risk factor for exacerbated lipid peroxidation and disease in murine retinitis pigmentosa. | Redox Biol | 2026 | 41610519 | PubTator, text mining | PubMed |
| Expanding the therapeutic landscape of PDE10A inhibition through alchemical absolute binding free energy calculations and in-vitro evaluation. | Protein Sci | 2026 | 41603286 | PubTator, text mining | PubMed |
| Family-Wide Dysregulation of Phosphodiesterases Alters cAMP/cGMP Microdomains in Thoracic Aortic Aneurysm. | J Cardiovasc Dev Dis | 2026 | 41590850 | PubTator, text mining | PubMed |
| Integrative multi-omics analyses identify key genes and elucidate bidirectional regulatory mechanisms in thyroid dysfunction. | PLoS One | 2026 | 41570039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10846/papers